Status:
WITHDRAWN
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
Cellestis
Conditions:
Chronic Liver Disease
TB
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Tuberculosis (TB) is an important cause of morbidity and mortality in organ transplant recipients. Management of tuberculosis in this setting is challenging due to the complexity of diagnosis and the ...
Detailed Description
* Review and record the results of the test/procedures (x-rays, CT-scans, etc.) that are part of the subject's clinical care and the results will become part of the research record. In addition, labor...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age ≥ 18
- Chronic liver disease on the waiting list or being wait listed for liver transplantation
- Undergoing a PPD test as part of their clinical care
- Exclusion Criteria
- Unable to provide informed consent
- Previous history of immediate hypersensitivity to TST
- Previous severe local ulceration with TST
- Suspected active TB
Exclusion
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00424684
Start Date
January 1 2007
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213